European Journal of Neurology · 2021 · 28 citations · 32 references
Life SciencesGeneticsMolecular GeneticsMedical GeneticsNeurodegenerationNeurogeneticsGenotype-phenotype Association AnalysisMovement Disorder GeneticsNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersClinical Diagnosis Of ParkinsonismClinical VariantsGenotype-phenotype AssociationsGenotype-phenotype LinkageGenotype-phenotype ScreeningNeurodegenerative Disease EpidemiologyParkinson's Disease GeneticsPhenotype-genotype Correlation
BACKGROUND AND PURPOSE: Variants in the glucocerebrosidase (GBA) gene are recognized as a common and important genetic risk factor for Parkinson disease (PD). However, the impact of variant severity on the clinical phenotype of PD in the Chinese population remains unclear. Thus, the present study aimed to determine the frequency of GBA-related PD (GBA-PD) and the relationship of GBA variant severity with clinical characteristics in a large Chinese cohort. METHODS: Long-range polymerase chain reaction and next generation sequencing were performed for the entire GBA gene. GBA variant severity was classified into five classes: mild, severe, risk, complex, and unknown. RESULTS: Among the total 737 PD patients, 47 GBA variants were detected in 79 (10.72%) patients, and the most common GBA variants were R163Q, L444P, and R120W. Complete demographic and clinical data were obtained for 673 patients, which revealed that 18.50% of early onset PD patients had GBA variants. Compared with patients without GBA variants, GBA-PD patients experienced PD onset an average of 4 years earlier and had more severe motor and nonmotor symptoms. Patients carrying severe and complex variants had a higher burden of nonmotor symptoms, especially depression, and more mood/cognitive and gastrointestinal symptoms than patients carrying mild variants. CONCLUSIONS: GBA-PD is highly prevalent in the Chinese population. The severity of GBA variants underlies distinct phenotypic spectrums, with PD patients carrying severe and complex variants seeming to have similar phenotypes. PD patient stratification by GBA variant severity should become a prerequisite for selecting specific treatments.
32
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky, Mike A. Nalls, Jan Aasly et al. · New England Journal of Medicine · 2009 · 2.1K citations · Full text
Joseph R. Mazzulli, You-Hai Xu, Ying Sun et al. · Cell · 2011 · 1.3K citations · Full text
Variable expression of Parkinson's disease
Joseph Jankovic, Michael McDermott, Jonathan Carter et al. · Neurology · 1990 · 1.3K citations
Medicine, Neurology, Neuroscience +17
К. Ray Chaudhuri, Pablo Martínez‐Martín, Anthony H.V. Schapira et al. · Movement Disorders · 2006 · 1.1K citations